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Capsular polysaccharide (CPS) is a major virulence factor in Vibrio vulnificus, and encapsulated strains have
an opaque, smooth (OpS) colony morphology, while nonencapsulated strains have a translucent, smooth (TrS)
colony morphology. Previously, we showed that OpS and TrS parental strains can yield a third colony type,
rugose (R), and that the resulting strains, with the OpR and TrR phenotypes, respectively, form copious
biofilms. Here we show that while OpR and TrR strains both produce three-dimensional biofilm structures that
are indicative of rugose extracellular polysaccharide (rEPS) production, OpR strains also retain expression of
CPS and are virulent in an iron-supplemented mouse model, while TrR strains lack CPS and are avirulent.
Chlorine resistance assays further distinguished OpR and TrR isolates as exposure to 3 g/ml NaOCl
eradicated both OpS and OpR strains, while both TrS and TrR strains survived, but at rates which were
significantly different from one another. Taken together, these results further emphasize the importance of
CPS for virulence of V. vulnificus and establish a correlation between CPS expression and chlorine sensitivity
in this organism. Using reverse transcriptase PCR, we also identified a nine-gene cluster associated with both
CPS and rEPS expression in V. vulnificus, designated the wcr (capsular and rugose polysaccharide) locus, with
expression occurring primarily in R variants. The latter results set the stage for characterization of functional
determinants which individually or collectively contribute to expression of multiple EPS forms in this
pathogen.
Vibrio vulnificus is a gram-negative marine and estuarine bac-
terium capable of causing severe disease in susceptible individu-
als. This bacterium is normally found in fish and shellfish, includ-
ing oysters. Several medical conditions can predispose a person to
being susceptible to infection by this organism, including diabetes,
liver disease, hemachromatosis, and a compromised immune sys-
tem. When people with such conditions consume raw oysters or
other seafood containing V. vulnificus, they are at risk of devel-
oping a rapidly progressing primary septicemia that can be fatal
within 24 to 48 h. In an otherwise healthy individual, if a break in
the skin is exposed to seawater containing this organism, a severe
wound infection may develop that could necessitate amputation if
treatment is not begun soon after the onset of symptoms. V.
vulnificus does not infect as many people as other members of the
genus Vibrio, but it is the leading reported cause of death from the
consumption of seafood in the United States (28, 48).
V. vulnificus produces several virulence factors, including mul-
tiple enzymes, siderophores, RtxA toxin, and a polysaccharide
capsule (for a review, see reference 15). While the other factors
may assist in virulence, the capsular polysaccharide (CPS) is con-
sidered a major virulence factor and has been reported to protect
the bacteria from phagocytosis and complement-mediated killing
by the host immune system. When grown on solid media, colonies
of cells producing CPS appear opaque (Op), smooth (S), and
mucoid (4, 17). OpS strains are capable of undergoing spontane-
ous phase variation and producing translucent (Tr) strains that
are smooth and sticky and express little or no CPS (59, 65).
Several studies have documented that OpS strains are virulent,
while TrS strains are avirulent in an iron-supplemented mouse
model (21, 44–46, 61, 64).
As we reported previously (14), V. vulnificus is capable of
producing a third colony morphotype, a rugose (R) variant,
which produces copious amounts of extracellular polysaccha-
ride (EPS) and forms robust biofilms. Biofilms are accumula-
tions of cells encased in an exopolymeric substance produced
by cells attached to each other and/or a surface (11, 43). Unlike
the R variants, the OpS and TrS variants do not form appre-
ciable amounts of biofilms. The R phenotype in Vibrio cholerae
was described in the 1930s (54), but only recently have many of
the genes responsible for the production of the rugose EPS
(rEPS), also known as Vibrio polysaccharide, been reported (1,
33, 62, 63). The chemical composition of the rEPS of nonen-
capsulated R strains of V. cholerae has been shown to differ
from the chemical composition of the CPS of encapsulated V.
cholerae S strains (63), while the S and R forms exhibit differ-
ential expression of rEPS genes (62). As V. vulnificus R vari-
ants have been described only recently, genes associated with
rEPS expression in phase variants of this species have not been
identified.
In this study we further characterized R derivatives of both
OpS and TrS parents, with the OpR and TrR phenotypes,
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respectively, and found additional significant differences be-
tween them in terms of pathogenicity in an iron-supplemented
mouse model, expression of CPS, and resistance to chlorine.
This is also the first report of a gene cluster in V. vulnificus
whose genes are preferentially expressed in R variants but
which includes determinants for both rEPS and CPS expres-
sion.
MATERIALS AND METHODS
Bacterial strains and growth conditions. The bacterial strains used were the
OpS strain V. vulnificus 1003(O) and the following previously described deriva-
tives of this strain (14, 45): BG(R) (OpR; spontaneous R derivative), AZ(T)
(TrS; spontaneous Tr derivative), ABZ1(T) (TrS; wcvA::mini-Tn10), ABZ1(R)
(TrR; wcvA::mini-Tn10), RJS2(T) (TrS; wcvF::mini-Tn10), and TDB3(T) (TrS;
wcrI::mini-Tn10). All V. vulnificus strains were grown in heart infusion broth
(Difco, Detroit, MI) supplemented to 2% NaCl (HI broth). For growth on agar
plates, 18 g of agar (Difco) per liter of HI was added. Broth cultures were
incubated at 30°C and 200 rpm; plates were incubated at 30°C for 18 to 48 h.
Phenotypic switching assays were performed as previously described (14).
Virulence assays. The pathogenicity of individual V. vulnificus strains was
evaluated by using the iron-supplemented mouse model. Each mouse in a group
(n  5) of 6-week-old male ICR mice (Harlan Sprague-Dawley, Indianapolis,
IN) was inoculated intraperitoneally with 0.5 ml of one dilution of a mid-
exponential-phase bacterial culture in phosphate-buffered saline (PBS) (pH 7.2),
followed by 0.2 ml of ferric ammonium citrate (80 g) in PBS, as described by
Wright et al. (60). Five serial dilutions and five groups of mice were typically used
for each bacterial strain. Control mice received injections of ferric ammonium
citrate in PBS. After 48 h, any remaining live mice were euthanized by asphyx-
iation with CO2, followed by cervical dislocation. Mice were housed in a BSL2
room in the Department of Laboratory Animal Medicine vivarium at the LSU
School of Veterinary Medicine, and the experiment was approved by the LSU
Institutional Animal Care and Use Committee. Spleens harvested from mice that
died from V. vulnificus infection were macerated using a sterile syringe plunger
in PBS and strained through a sterile mesh screen to remove connective tissue,
and the resulting solutions were serially diluted and plated onto HI agar plates.
Chlorine resistance assay. V. vulnificus strains were analyzed to determine
their resistance to chlorine as described previously for V. cholerae (63). Only
newly purchased NaOCl (6%) was used, and the sealed containers were not
opened until immediately prior to dilution to obtain a concentration of 3 g/ml
in PBS. Each culture was started using a representative colony of a phenotype;
approximately 107 mid-exponential-phase cells were exposed to either PBS or 3
g/ml NaOCl for 5 min, which was followed by dilution and plating. The exper-
iments were conducted at least three times, and the log mean  standard error
survival values are reported below. The percent survival was calculated as fol-
lows: 100  (number of CFU from NaOCl-treated cultures/number of CFU from
PBS-treated cultures). The survival in PBS was defined as 100%. Data were
analyzed by using a two-way analysis of variance (ANOVA) in the SAS/STAT
version 8 program (42). We performed a two-way ANOVA for the log-trans-
formed survival values to compare strain and treatment levels with interaction
(treatment and strain, where treatment was NaOCl or PBS). The two-way
ANOVA explained 98.65% of the variability in the survival values. To determine
a significant interaction effect, we performed a pairwise mean comparison of the
log-transformed data with a Bonferroni adjustment (probability level,  
0.05/16 or   0.003125).
Visualization of CPS and rEPS. For transmission electron microscopy (TEM),
isolated colonies were obtained and treated as described previously (53), with the
following modifications. Cells were fixed in 5% glutaraldehyde in 0.1 M cacody-
late buffer (pH 7) for 2 h and then filtered onto a 0.2-m polycarbonate filter and
gently rinsed three times with buffer. Cells were then treated with polycationic
ferritin (final concentration, 1.0 mg/ml; Sigma, St. Louis, MO) for 30 min and
rinsed in buffer. Stained cells were then treated with 2% osmium tetroxide for
1 h, rinsed with water, and stained with 0.5% uranyl acetate for 1 h. Samples were
dehydrated with ethanol and infiltrated with a 1:1 mixture of ethanol and LR
White resin overnight, after which the samples were infiltrated with 100% LR
White for 2 h. They were then embedded in LR White resin at 60°C, sectioned,
stained with Reynolds lead citrate, and imaged with a JEOL 100CX TEM.
Isolated colonies selected for scanning electron microscopy (SEM) were re-
moved from an agar plate with the underlying agar attached, placed on filter
paper in a petri dish, and vapor fixed overnight with 4% osmium tetroxide. The
agar plug was then placed on an adhesive-coated SEM stub, air dried, and
treated with a graphite suspension to enhance conductivity. Samples were then
sputter coated with Au-Pd (60:40) with an Edwards S-150 sputter coater and
imaged with a Cambridge 260 Stereoscan SEM.
Gene identification and primer design. Genes previously described as essential
to or associated with CPS production in V. vulnificus or rEPS production in V.
cholerae (1, 45, 58, 63) were selected, and their nucleotide sequences were
obtained from GenBank and submitted to a BLAST (3) search to identify
potential homologs in the genome sequences of V. vulnificus strains YJ016 (8)
and CMCP6 (25). Homologous sequences in multiple strains were aligned by
using the program Align Plus, version 2.0 (Scientific and Educational Software,
Cary, NC), and conserved regions were identified and used for primer design.
The control primers included universal primers for bacterial 16S rRNA genes
(52) and primers that were specific for the following V. vulnificus genes: gyrB and
a 23S rRNA gene. Primers were designed by using the program Primer Design,
version 2 (Scientific and Educational Software), subjected to a BLAST search to
determine uniqueness and proper location, and synthesized by Sigma-Genosys
(The Woodlands, TX), and the primers used are listed in Table 1.
Nucleic acid isolation and purification. Genomic DNA was isolated from
overnight cultures of individual strains by using a PureGene DNA isolation kit
(Gentra Systems, Minneapolis, MN) along with the protocol provided by the
manufacturer. For isolation of total RNA, isolated colonies with the desired
phenotype were selected and used to inoculate a 3-ml HI broth culture for each
phase variant. The cultures were incubated overnight and then were prepared for
RNA isolation. For mid-exponential and late-exponential RNA isolation, an
overnight culture was diluted 1:100 into 10 ml fresh HI broth (30°C) and incu-
bated until the culture optical densities at 600 nm reached approximately 0.400
and 1.000, respectively. To better synchronize growth, the cultures were diluted
again 1:100 in 10 ml of 30°C HI broth and incubated until the desired optical
densities at 600 nm were reached again, when multiple 1-ml aliquots were
harvested into 1.5-ml tubes. Total RNA was isolated using TRI REAGENT
(Molecular Research Center, Inc., Cincinnati, OH) by following the manufac-
turer’s protocol. For stationary-phase RNA isolation, 0.5-ml aliquots of the
overnight cultures were used for the TRI REAGENT protocol. Each culture
used for RNA isolation was also streaked onto HI agar plates, and after incu-
bation the plates were scrutinized to verify that the correct phenotype was
expressed uniformly. Dried pellets of RNA were rehydrated in nuclease-free
H2O (Ambion, Inc., Austin, TX), subjected to DNase (Promega Corp., Madison,
WI) treatment, and then purified using an RNeasy kit (Qiagen, Inc., Valencia,
CA) as suggested by the manufacturers. The RNA concentration was determined
by using the A260/A280 values, and the integrity of the total RNA was verified by
agarose gel electrophoresis.
PCRs were performed with purified RNA samples to determine if the samples
contained any residual contaminating DNA. Genomic DNA samples (positive
controls), as well as nuclease-free H2O (negative control), were examined in
parallel reactions. Each 25-l (final volume) reaction mixture contained 2.5 l of
10 buffer, 1.5 l of MgCl2 (25 mM), 1 l of a deoxynucleoside triphosphate
(dNTP) mixture (each dNTP at a concentration of 2.5 mM; Applied Biosystems,
Foster City, CA), 0.5 l of each primer (20 M) specific for a V. vulnificus 1003
23S rRNA gene (primers O212-F [5-CGATAAGCGTAGATGAGGCA-3] and
O212-R [5-GTACGCAGTCACACCACGAA-3]), 0.2 l of AmpliTaq poly-
merase (5 U/l; Applied Biosystems), 100 ng of template (RNA, DNA, or
nuclease-free H2O), and nuclease-free H2O. The PCRs were performed with a
Perkin Elmer Gene Amp 2400 using an initial temperature of 94°C for 1 min,
followed by 35 cycles consisting of 94°C for 1 min, 55°C for 1 min, and 72°C for
2 min and then a final extension at 72°C for 5 min and holding at 4°C. PCR
mixtures were examined by agarose gel electrophoresis, and when there was
evidence of DNA contamination, the DNase treatment and PCR were repeated.
Gene detection PCR, gene linkage analysis, and RNA dot blotting. All primer
sets were optimized for PCR using genomic DNA from each of the phase
variants studied. For detection PCRs the cycling conditions described above for
detecting DNA contamination in RNA were used. The annealing temperature
was adjusted to 50 or 60°C for some primer sets, and most primer sets required
addition of dimethyl sulfoxide (DMSO) (10% of the total reaction volume)
(Table 1). For CPS and rEPS gene detection PCRs, the following modified
reaction mixture components were used: 2.5 l of 10 buffer, 1.5 l of MgCl2 (25
mM), 2 l of a dNTP mixture (each dNTP at a concentration of 2.5 mM), 1.25
l of each primer (20 M), 0.2 l of AmpliTaq polymerase, 2.5 l of DMSO (if
needed), 1 l of template (100 ng/l DNA or nuclease-free H2O), and nuclease-
free H2O to bring the total volume to 25 l. PCR products were analyzed by
agarose gel electrophoresis.
For gene linkage analysis, PCR was performed with genomic DNA of strain
1003(O) (OpS) using various combinations of the primers listed in Table 1.
PfuTurbo polymerase (Stratagene) was used, and the reaction mixtures and

























































running conditions were those recommended by the manufacturer. Southern
blotting was performed as described previously (6), except that transfer was
performed with a VacuGene XL vacuum blotting system (Amersham Pharmacia
Biotech, Inc., Piscataway, NJ) used according to the manufacturer’s instructions.
V. vulnificus 1003(O) genomic DNA was isolated as described above. Fragments
specific for the wcrC, wcrF, and wcrH genes were generated by performing PCRs
with primers RUG18 and RUG19, RUG33 and RUG34, and CAP25 and CAP26
(Table 1), respectively, and these fragments then were used as templates for
generation of radioactive probes by using an NEBlot kit (New England Biolabs,
Ipswich, MA) along with 3,000 Ci/mmol [-32P]dATP. Unincorporated nucleo-
tides were removed from completed reaction mixtures by using a Microspin
S-300 HR column (Amersham Pharmacia Biotech, Inc.).
For RNA dot blotting, total RNA was isolated from mid-exponential cultures as
described above, and 5 g of total RNA of each strain was bound in triplicate to a
nylon membrane by vacuum blotting using a Bio-Dot microfiltration apparatus
(Bio-Rad, Hercules, CA). Fragments specific for portions of the wcrA, wcrD, and
wcrJ genes were generated by performing PCRs with primers RUG13 and RUG14,
RUG19 and RUG20, and RUG45 and RUG46 (Table 1), respectively; these frag-
ments were then used to generate radiolabeled probes which were used in hybrid-
ization reactions using the conditions described previously (6). Completed dot blots
were exposed to a phosphor screen for 16 h, and the screen was then scanned with
a Typhoon scanner (GE Healthcare, Piscataway, NJ). Images were quantified using
ImageQuant volume quantitation (GE Healthcare). Levels of induction were calcu-
lated by dividing the sum of the pixel values above the background level in each spot
by the average sum of the pixel values for the 1003(O) (OpS) spots. The levels of
induction for each set of spots were averaged for each strain, and the significance of
the mean difference for each gene for the TrR strain compared to either the OpS or
TrS strain was evaluated using a two-sample t test.
TABLE 1. Primers used in this studya





Genes used as controls
RRN1A Forward primer for 16S rRNA geneb 5-TAACACATGCAAGTCGAACG-3 330 60 
RRN2B Reverse primer for 16S rRNA geneb 5-CCCATTGTGCAATATTCCCC-3
O212-F Forward primer for 23S rRNA gene 5-CGATAAGCGTAGATGAGGCA-3 483 55 
O212-R Reverse primer for 23S rRNA gene 5-GTACGCAGTCACACCACGAA-3
GYRB-F Forward primer for gyrB (VV0014)c 5-GGTTACTCAGTTGAACGCCA-3 294 50 
GYRB-R Reverse primer for gyrB (VV0014) 5-CGAGATTCCTTAATCAGCCA-3
Genes associated with CPS
expression in V. vulnificusd
CAP7 Forward primer for wcvAe 5-AGTCTAACGAACTTATGGCT-3 384 50 
CAP8 Reverse primer for wcvA 5-TCGCTTCAATACCAAGTTCA-3
CAP17 Forward primer for wcvFe 5-TAAGCCTCAAGCGTTGACTG-3 443 60 
CAP18 Reverse primer for wcvF 5-TTATGGCTCCTCTTAAGTGC-3
CAP25f Forward primer for wcrH (VVA0390) 5-CATCGAGACATGGAGAGAAC-3 369 55 
CAP26 Reverse primer for wcrH (VVA0390) 5-GTAGAGTGGCAGATCGTACA-3
CAP27 Forward primer for wcrI (VVA0389) 5-TACCAATCTAACGCCGGCAA-3 199 60 
CAP28f Reverse primer for wcrI (VVA0389) 5-TGTCACGCAACTGCTGTTCT-3
CAP37 Forward primer for wza (VV0337) 5-GCGATATCATCCACGTGCCA-3 211 55 
CAP38 Reverse primer for wza (VV0337) 5-ATATCCGCCATGCGTTCAGA-3
Genes associated with rEPS
expression in V. cholerae
with homologs in V. vulnificusg
RUG13f,h Forward primer for wcrA (VVA0395) 5-CGAGAGAGATGAGAGCAATG-3 162 55 
RUG14 Reverse primer for wcrA (VVA0395) 5-GCTGTGGTGTCTGAGAACTG-3
RUG15f Forward primer for wcrB (VVA0394) 5-CAAGAGCATACGACCTGGAC-3 198 55 
RUG16f Reverse primer for wcrB (VVA0394) 5-TTCCTCTCGCAATACGCCAC-3
RUG17 Forward primer for wcrC (VVA0393) 5-TGGCGAGGATGACTTATCAA-3 186 55 
RUG18f Reverse primer for wcrC (VVA0393) 5-CGGAACTTATTAATCGAGAC-3
RUG19f,h Forward primer for wcrD (VVA0392) 5-ACGCAGACCTCCACTAGAGA-3 209 55 
RUG20 Reverse primer for wcrD (VVA0392) 5-CCTGTAGCGTGTTCAGTAGA-3
RUG33 Forward primer for wcrF (VVA0391) 5-GAAGGTGCAGGAAGAGTTGA-3 475 55 
RUG34f Reverse primer for wcrF (VVA0391) 5-TAGATAACCAGCGTTGCCGA-3
RUG45h Forward primer for wcrJ (VVA0388) 5-AATCCAATGAGCAGCGAAGTCC-3 375 55 
RUG46 Reverse primer for wcrJ (VVA0388) 5-AGCGATACGCCATGTTACTCC-3
a Primer sequences were designed for this study except where indicated otherwise.
b Forward and reverse primer sequences were obtained from the study of Vliegenthart et al. (52).
c The gene designations for V. vulnificus YJ016 consist of VV (for genes located on the large chromosome) or VVA (for genes located on the small chromosome),
followed by the gene number.
d See references 45 and 58.
e In strain YJ016 there are no genes with significant identity to wcvA and wcvF of strain 1003.
f Primers used to generate probes for Southern hybridization (see Materials and Methods for details).
g See references 1 and 8.
h Primers used to generate probes for RNA dot blot hybridization (see Materials and Methods for details).

























































Two-step cDNA generation and amplification PCR. Once conditions were
optimized for the different primer sets and the genes of interest had been
detected in the genomic DNA of the phase variants, reverse transcriptase PCR
(RT-PCR) was used to generate cDNA from purified total RNA using Super-
Script II RT (Invitrogen Corp., Carlsbad, CA) and a modification of the sug-
gested protocol. Briefly, 2 l of total RNA (100 ng/l), 2.8 l of a random
hexamer primer (100 ng; Sigma-Genosys), 1 l of a dNTP mixture (each dNTP
at a concentration of 10 mM; Stratagene), and 6.2 l of nuclease-free H2O were
combined, incubated at 65°C for 5 min and then on ice for 2 min, and pulse
centrifuged. The following components were then added: 4 l of 5 First Strand
buffer, 2 l of 0.1 M dithiothreitol, and 1 l of RNasin (40 U/l; Promega). The
reaction mixtures were mixed gently and incubated at room temperature for 10
min, which was followed by incubation at 42°C for 15 min to equilibrate the
mixture. Then either 1 l (200 U) of SuperScript II RT or 1 l of nuclease-free
H2O was added, and the tube contents were mixed gently and incubated at 42°C
for 50 min. RT was added to an additional negative control reaction mixture with
nuclease-free H2O as the template to identify possible contamination from the
recombinant RT. This control reaction was performed in tandem with the other
reactions. The reaction mixtures were inactivated by incubation at 70°C for 15
min, followed by incubation on ice for 2 min and pulse centrifugation. cDNA was
stored at 20°C.
Second-strand and amplification PCRs were performed with cDNA samples
from the different time points. Control reactions with genomic DNA or nuclease-
free H2O as the template were performed in parallel. The reaction mixtures
consisted of 2.5 l of 10 buffer, 1.5 l of MgCl2 (25 mM), 0.5 l of a dNTP
mixture (each dNTP at a concentration of 2.5 mM), 0.5 l of each primer (20
M), 0.2 l of AmpliTaq polymerase, 2.5 l of DMSO (if needed), 1 l of
template (cDNA, 100 ng/l genomic DNA, or nuclease-free H2O), and nuclease-
free H2O to bring the total volume to 25 l. The cycling parameters were the
same as those described above except that the PCR was performed for only 30
cycles at the empirically determined annealing temperature. The reactions were
performed with either a Perkin Elmer Gene Amp 2400 (24 wells) or a Bio-Rad
MyCycler (96 wells). All RT-PCRs were performed at least twice with separate
cDNA preparations. PCR products were analyzed by agarose gel electrophoresis,
and reactions were scored qualitatively for gene expression as follows: 3,
brightest RT-PCR products observed; 2, RT-PCR products with intermediate
brightness; , dim but significant RT-PCR products; tr, trace (very faint RT-
PCR products); 0, no RT-PCR product. Each set of reactions was scored inde-
pendent of the other sets; thus, the qualitatively estimated levels of expression
were not carried over from one gene to another.
RESULTS
OpR V. vulnificus strains are virulent in the iron-supple-
mented mouse model and retain production of CPS. Previ-
ously, we demonstrated that the OpR strain BG(R), like its
OpS parent, 1003(O), was relatively resistant to killing by nor-
mal human serum (NHS), while the TrR strain ABZ1(R), like
its TrS parent ABZ1(T), was sensitive to NHS (14). To deter-
mine if survival in NHS in vitro correlates with pathogenicity in
vivo, we tested strains 1003(O) (OpS), BG(R) (OpR),
ABZ1(T) (TrS), and ABZ1(R) (TrR) using the iron-supple-
mented mouse model. Typically, groups of five mice were in-
oculated with a given strain at concentrations ranging from
approximately 100 to 104 or 105 CFU, followed by injection of
ferric ammonium citrate as described previously (60). Mice
were then monitored for 48 h for survival. Similar to the results
of other workers (45), the OpS strain was virulent, with as few
as 1.9  102 CFU resulting in the death of 80% of the mice
infected and 100% killing observed at the higher dose tested
(Table 2). Also as expected (45), the TrS strain was avirulent
(i.e., none of the infected mice died) at all bacterial concen-
trations tested (range, 2.3  100 to 2.3  104 CFU) (Table 2).
Meanwhile, consistent with the previous NHS results, the OpR
strain was also virulent, with as few as 4.3  102 CFU resulting
in the death of 20% of the mice and 100% killing observed at
the higher doses examined, while the TrR strain was avirulent
at all concentrations tested (range, 1.3  100 to 1.3  105
CFU) (Table 2). While the levels of mortality resulting from
the 102-CFU doses of the OpS (80%) and OpR (20%) strains
were different, there was no statistically significant difference
between these results. Spleens of mice that died from infection
with OpS bacteria yielded only OpS colonies when they were
plated on appropriate agar media, while spleens of mice that
died from infection with OpR bacteria yielded only OpR col-
onies (data not shown). These findings eliminated the possi-
bility that either morphotype of bacteria had undergone phe-
notypic switching in vivo and therefore confirmed that the
deaths of mice infected with a particular phase variant were
caused by that type of variant.
The apparent correlation between survival in vitro (in NHS)
and virulence in vivo (in mice) for the encapsulated OpS strain
1003(O) and its OpR derivative BG(R) led us to speculate that
the latter strain may have retained the ability to produce CPS,
while also producing rEPS. As polycationic ferritin staining has
been used to visualize the capsular material of several bacteria
(22–24, 51), whole colonies of strains 1003(O) (OpS), BG(R)
(OpR), ABZ1(T) (TrS), and ABZ1(R) (TrR), as well as the
spontaneous TrS strain AZ(T), were stained with polycationic
ferritin, prepared, sectioned, and then viewed by TEM (Fig. 1).
Both the OpS strain and its OpR derivative had a thick layer of
ferritin-stained material around each cell, as well as between
cells; there did not appear to be any difference in the thickness
of this layer in the two strains (Fig. 1A and B). In contrast, the
acapsular, TrS transposon mutant ABZ1(T) and its TrR de-
rivative ABZ1(R) had little or no ferritin-stained material sur-
rounding the cells (Fig. 1C and D), while the spontaneous TrS







1003(O) (OpS) 1.9  104 100
1.9  102 80
1.9  101 0
1.9  100 0
BG(R) (OpR) 4.3  105 100
4.3  104 100
4.3  102 20
4.3  101 0
4.3  100 0
ABZ1(T) (TrS) 2.3  104 0
2.3  102 0
2.3  101 0
2.3  100 0
ABZ1(R) (TrR) 1.3  105 0
1.3  104 0
1.3  102 0
1.3  101 0
1.3  100 0
a BG(R) is a spontaneous OpR derivative of 1003(O); ABZ1(T) is a transpo-
son-induced TrS derivative of 1003(O); and ABZ1(R) is a spontaneous TrR
derivative of ABZ1(T). Strains ABZ1(T) and ABZ1(R) were rendered acapsular
by a transposon insertion in wcvA (45).
b Groups of five mice were inoculated intraperitoneally with 0.5 ml of one
dilution of a mid-exponential-phase bacterial culture in PBS (pH 7.2), followed
by 0.2 ml of ferric ammonium citrate (80 g) in PBS as described previously (60).
c Mortality was determined at 48 h postinoculation.

























































strain AZ(T) had minimal ferritin-stained material on the cell
surfaces and some stained material was in the spaces between
cells (Fig. 1E). The protocol used apparently did not allow
visualization of rEPS, which, if present, should have been most
unambiguously identifiable for the TrR strain ABZ1(R), the R
derivative of the acapsular transposon mutant ABZ1(T) (TrS).
However, ABZ1(R) (TrR), as well as R colonies derived from
other TrS strains, tended to float and lose their cohesion dur-
ing the preparation process (data not shown), which we inter-
preted to mean that the rEPS around these cells was being
dissociated. It is possible that the aqueous fixation process used
for preparation of the cells for viewing by TEM led to disso-
lution of the rEPS and separation of the rEPS from the cells,
while the attached CPS remained.
We previously showed that OpR and TrR V. vulnificus
strains formed profuse biofilms on the surfaces of static cul-
tures (14); however, the three-dimensional (3-D) biofilm struc-
tures resulting from production of copious amounts of rEPS
were not verified for these strains. As mentioned above, bio-
films have been defined as an accumulation of cells that are
encased in an exopolymeric substance produced by the cells
and that are attached to each other and/or a surface (11, 43);
this definition includes bacterial colonies (12, 27). To verify
that V. vulnificus R isolates indeed produce the 3-D biofilm
structures, we analyzed fixed colonies of strains 1003(O)
(OpS), BG(R) (OpR), ABZ1(T) (TrS), and ABZ1(R) (TrR),
both whole and fractured, by using SEM, a process which
notably did not involve an aqueous fixation step. As shown in
Fig. 2A and B, the OpS and TrS strains had a smooth colony
surface and a flat architecture, reminiscent of a biofilm mono-
FIG. 1. Electron micrographs of polycationic ferritin-stained whole colonies of V. vulnificus phase variants. Whole colonies grown on HI agar
were stained with polycationic ferritin, sectioned, and viewed by TEM as described in the text. The following strains were examined:
(A) 1003(O) (OpS); (B) BG(R) (OpR); (C) ABZ1(T) (TrS); (D) ABZ1(R) (TrR); and (E) AZ(T) (TrS). Bars  1 m.

























































layer. Colonies of the R strains BG(R) (OpR) and ABZ1(R)
(TrR), however, had a wrinkled surface and a distinct 3-D
architecture reminiscent of classic biofilm structure (10, 27,
47), which included pillars, channels, and arches (Fig. 2C, D, E,
and F). Taken together, the polycationic ferritin staining TEM
and whole-colony SEM results support the notion that both
OpR and TrR strains of V. vulnificus indeed produce copious
amounts of rEPS (which was evident only when SEM was
used), while only the OpR variant also produces CPS (as re-
vealed by TEM).
TrS and TrR strains survive exposure to chlorine, while
OpS and OpR strains do not. It has been reported that V.
cholerae R variants are more resistant to chlorine than nonen-
capsulated S parental strains (2, 31, 37, 63). Resistance to
chlorine disinfectant was tested here using four V. vulnificus
phase variants, and the results are shown in Fig. 3. While OpR
V. vulnificus strain BG(R) and its OpS parent 1003(O) were
both totally eradicated by exposure to 3 g/ml NaOCl for 5
min, the TrS strain ABZ1(T) and its TrR derivative ABZ1(R)
FIG. 3. Chlorine disinfectant differentially kills phase variants of V.
vulnificus 1003. Individual strains were exposed to 3 g/ml NaOCl for
5 min as described previously (63). The large bars indicate the log
means and the error bars indicate the standard errors for survival in
three independent experiments for strains 1003(O) (OpS), BG(R) (OpR),
ABZ1(T) (TrS), and ABZ1(R) (TrR).
FIG. 2. V. vulnificus R colonies are solid-air interface 3-D biofilms. Whole colonies grown on HI agar were vapor fixed with 4% osmium
tetroxide and viewed by SEM as described in the text. (A) 1003(O) (OpS); (B) ABZ1(T) (TrS); (C, E, and F) BG(R) (OpR); (D) ABZ1(R) (TrR).
(A, B, C, and E) Bars  100 m; (D) bar  50 m; (F) bar  20 m.

























































survived, but the mean viable cell counts were 2 and 3 logs
lower, respectively, than those for the PBS-treated controls.
The level of survival of strain ABZ1(T) (TrS) (1.06%  0.68%
[mean  standard deviation]) was almost ninefold greater than
that of the TrR strain ABZ1(R) (0.12%  0.16%). We ana-
lyzed the data using a two-way ANOVA and the log-trans-
formed survival values and found that the differences between
the PBS and NaOCl treatments were significant (P  0.0001)
for all strains. There were no statistically significant differences
between the OpS and OpR strains in either the PBS- or
NaOCl-treated groups. However, the differences in survival
after NaOCl treatment between the Tr and Op strains shown
in Fig. 3 were significant (P  0.0001), irrespective of the S or
R phenotype. To determine the significant interaction effect,
we performed a pairwise mean comparison with a Bonferroni
adjustment (probability level,   0.05/16 or   0.003125);
this test showed that the level of survival of the TrS strain was
significantly greater than that of the TrR strain (probability
level,   0.0031) after both strains were treated with NaOCl.
Thus, the results obtained for the TrS and TrR strains contrast
with those described previously for R and nonencapsulated S
strains of V. cholerae (2, 31, 37, 63); meanwhile, the chlorine
results in their entirety obtained in this study suggest a role for
CPS in the chlorine sensitivity of V. vulnificus, as discussed
below.
Identification of a CPS and rEPS locus in V. vulnificus. As S
and R forms of V. cholerae show differential expression of rEPS
genes (62), we sought to identify genes that may be expressed
differentially in OpS, TrS, and R isolates of V. vulnificus. Most
of 36 genes known to be involved in CPS expression in V.
vulnificus (45, 58) or identified as homologs of genes required
for rEPS production in V. cholerae (1, 63) were expressed at
some level in all five V. vulnificus phase variants, 1003(O)
(OpS), AZ(T) (TrS), BG(R) (OpR), ABZ1(T) (TrS), and
ABZ1(R) (TrR) (13), when they were screened by performing
RT-PCR with primers designed using conserved regions of
each gene. Strains were grown in HI broth at 30°C as described
in Materials and Methods, and Table 3 shows the qualitative
expression patterns of 10 of these genes chosen for further
analysis. The first five genes, designated wcrABCDF (see be-
low), are homologs of genes that have been associated with
rEPS expression in V. cholerae (1, 63), and these genes also
correspond to V. vulnificus YJ016 open reading frame (ORFs)
VVA0395 through VVA0391, which are part of a single locus
in that strain (8). Four of the remaining genes, wza, wcvA,
wcvF, and wcrI (previously designated wcvI), have been shown
to be required for CPS expression in V. vulnificus, while wcrH
(previously designated wcvH) is linked to wcrI (45, 58). The
RT-PCR data for the wcrABCDF genes indicate that they are
all preferentially expressed in R strains (Table 3). Generally,
their expression was greatest during mid-exponential growth
FIG. 4. Gene expression in V. vulnificus phase variants as measured
by RT-PCR: results of RT-PCR, second-strand PCR, and amplification
PCR for RNA from five phase variants at three different points in the life
cycle for the (A) wcrA and (B) wza genes. Second-strand and amplifica-
tion PCRs were performed with cDNA made using the following
RNA-RT combinations: lane 1, 1003(O) (OpS) with RT; lane 2,
1003(O) (OpS) with no RT; lane 3, AZ(T) (TrS) with RT; lane 4,
AZ(T) (TrS) with no RT; lane 5, BG(R) (OpR) with RT; lane 6,
BG(R) (OpR) with no RT; lane 7, ABZ1(T) (TrS) with RT; lane 8,
ABZ1(T) (TrS) with no RT; lane 9, ABZ1(R) (TrR) with RT; lane 10,
ABZ1(R) (TrR) with no RT; lane 11, H2O with RT. The following lanes
contained PCR controls: lane , genomic DNA; and lane , negative
(H2O) control. Lanes M contained a 100-bp marker. (New England Bio-
labs) ME, mid-exponential; LE, late exponential; ST, stationary phase.
TABLE 3. CPS and rEPS gene expression in V. vulnificus 1003 phase variants during different stages of growth as determined by RT-PCR
Gene
Expression in mid-exponential phase in the
following strainsa:
Expression in late-exponential phase in the
following strains:
Expression in stationary phase in the
following strains:
1003(O) AZ(T) BG(R) ABZ1(T) ABZ1(R) 1003(O) AZ(T) BG(R) ABZ1(T) ABZ1(R) 1003(O) BG(R) BG(R) ABZ1(T) ABZ1(R)
wcrA 0b 0 2 0  0 0  0 2 0 0 0 0 0
wcrB 0 0 3 tr 3 0 0 2 0 2 0 0 0 0 0
wcrC tr tr 3 tr 3 0 0  0  0 0 0 0 0
wcrD tr tr 3 tr 3  tr 2 0 2 0 0  0 2
wcrF tr tr 3 tr 3 0 0  0 2 0 0 0 0 tr
wcrH tr tr 2  2  0 3 0 3 0 0 0 0 
wcrI tr tr  0  0 0  0  0 0 tr 0 
wza 3 3 3 2 2   2  3     
wcvA    0 0 tr tr 0 0 0 0 0 0 0 0
wcvF tr      0   tr 0 0 tr 0 tr
a The phenotype of strain 1003(O) is OpS; AZ(T) is a spontaneous TrS derivative of 1003(O); BG(R) is a spontaneous OpR derivative of 1003(O); ABZ1(T) is a
transposon-induced TrS derivative of 1003(O); and ABZ1(R) is a spontaneous TrR derivative of ABZ1(T).
b 3, brightest RT-PCR products observed; 2, RT-PCR products with intermediate brightness; , dim but significant RT-PCR products; tr, trace (very faint
RT-PCR products); 0, no RT-PCR product observed.

























































and declined during late-exponential growth, and for the most
part they were not expressed during stationary phase. While
minimal expression of most of these genes was noted for the
non-R strains, wcrA appeared from this analysis to be ex-
pressed exclusively in the R isolates (Fig. 4A). The pattern of
expression of the wcrABCDF genes was markedly different
from the pattern of expression of many of the other exopo-
lysaccharide genes studied, such as wza, a CPS transport gene
of V. vulnificus, which has been reported to be missing in some
TrS strains (7, 58) and which, in contrast, was expressed in this
study by all phase variants at all time points tested (Table 3 and
Fig. 4B). Similarly, wcvA and wcvF showed expression profiles
inconsistent with the pattern of expression of the wcrABCDF
cluster. These two genes also showed some expression in all
phase variants tested, with the exception of wcvA in ABZ1(T)
(TrS) and its TrR derivative, ABZ1(R); this was expected,
however, since these strains contained a transposon insertion
in the wcvA gene.
In contrast to the expression patterns of the wza, wcvA, and
wcvF genes, the wcrH and wcrI genes showed preferential
expression in R strains, similar to the profiles for the wcrABCDF
cluster. Previously, it was shown that a transposon insertion in
the wcrI gene eliminated CPS expression in strain 1003(O)
(OpS), and although the sequences of wcrI and the adjoining
gene wcrH were determined, their location relative to other
exopolysaccharide genes was unknown (45). BLAST searches
performed in this study using the sequences of wcrH and wcrI
revealed that the predicted products of these two genes exhib-
ited high levels of deduced amino acid identity to the products
of two ORFs (VVA0390 [98%] and VVA0389 [99%], respec-
tively) adjacent to the wcrABCDF gene cluster (VVA0395
through VVA0391) in V. vulnificus YJ016. As shown in Fig. 5,
the entire locus includes the seven genes (wcrABCDFHI) iden-
tified here as being expressed predominantly in R strains, as
well as two additional ORFs, VVA0388 and VVA0387, which
were designated wcrJ and wcrK, respectively, in this study.
To analyze further the apparent differential expression of
the wcr genes, we used quantitative RNA dot blotting. Specif-
ically, total RNA isolated from exponentially growing cultures
of representative OpS, TrS, and R strains [strains 1003(O),
ABZ1(T), and ABZ1(R), respectively] was hybridized with
radioactive probes specific for the wcrA, wcrD, or wcrJ gene,
and digital images generated using a phosphorimager were
quantified using relevant software. As shown in Table 4, the
increases in expression of these three wcr genes ranged from
approximately 6-fold to 	30-fold for the TrR strain relative to
the OpS strain, and the levels of induction were even greater
for the TrR strain compared to the TrS isolate. Moreover,
using a two-sample t test, the mean difference in expression of
each wcr gene between the TrR strain and the OpS isolate was
found to be significant (for wcrA, P 
 0.01; for wcrD, P 
 0.01;
and for wcrJ, P 
 0.002), as was the difference in expression of
each wcr gene between the TrR strain and the TrS strain (for
wcrA, P 
 0.01; for wcrD, P 
 0.01; and for wcrJ, P 
 0.001).
These results thus confirm and extend our finding that wcr
genes show significantly greater expression in R strains than in
OpS and TrS isolates.
The inclusion of wcrHI in this cluster in strain YJ016 is
significant since, as stated above, a transposon insertion in the
wcrI gene in V. vulnificus strain 1003(O) (OpS) was found to
eliminate CPS production (45). This result raised the possibil-
ity that the wcrABCDFHIJK cluster may be involved in both
CPS and rEPS production. To begin to address this hypothesis
directly, we tested strain TDB3(T) (TrS) (45), a Tr derivative
of V. vulnificus 1003(O) (OpS) that contains a transposon in
wcrI, a predicted glycosyltransferase gene, for the ability to
undergo phase variation, as measured by the phenotypic
switching assay described previously (14). Briefly, this assay
involves daily passaging of HI broth cultures of a given strain
and plating cells for subsequent phenotypic analysis and quan-
tification of colonies every 5 days, as well as additional cycles of
passaging and plating for up to 15 days, if necessary. As deter-
mined by this assay, the OpS strain 1003(O) and many of its
TABLE 5. Phenotypic switching of V. vulnificus 1003 phase variantsa
Parent strain
(phenotype)b
% of total colonies with the following
phenotypes (avg  SD)
O Tr R
TDB3(T) (TrS) 0 100  0 0
RJS2(T) (TrS) 0 87.3  5.9 5.2  4.5
a Switching assays were conducted using three cycles of passaging and plating
as previously described (14). Broth cultures and plates were incubated at 30°C.
The total percentage of colonies for RJS2(T) (TrS) does not equal 100% because
some colonies had an intermediate phenotype.
b Both TDB3(T) (TrS) and RJS2(T) (TrS) were rendered acapsular due to a
transposon insertion in different CPS-related genes of strain 1003(O) (OpS) (45).
FIG. 5. wcr gene cluster in the genome of V. vulnificus YJ016.
Block arrows indicate the direction of transcription of the genes. Small
angled arrows indicate the position of putative promoters, including a
conserved ops (operon polarity suppressor) sequence (5), while the
hairpin structure after wcrK indicates the position of a putative rho-
independent transcriptional terminator. The open arrowhead below
wcrI indicates the location of the transposon insertion in strain
TDB3(T) (TrS) (45). The type of block arrow indicates the predicted
gene function or product, as follows: filled arrows, transferase genes;
arrows with horizontal stripes, polysaccharide export; arrow with di-
agonal stripes, biosynthesis genes; open arrows, genes encoding hypo-
thetical or unknown proteins. Asterisks indicate gene probes used in
Southern hybridization.
TABLE 4. Quantitative RNA dot blot analysis of wcr gene
expression in V. vulnificus 1003 phase variantsa
Strain
(phenotype)b
Induction of the following genes (mean  SD)c:
wcrA wcrD wcrJ
1003(O) (OpS) 1.00  0.97 1.00  0.20 1.00  0.04
ABZ1(T) (TrS) 0.84  0.13 0.85  0.12 0.40  0.22
ABZ1(R) (TrR) 31.37  2.89 14.06  1.45 5.89  0.35
a Five micrograms of total RNA isolated from mid-exponential cultures of
each strain were dot blotted in triplicate on nylon membranes and hybridized
with radiolabeled probes specific for the wcrA, wcrD, or wcrJ gene. Blots were
scanned to a phosphorimager and then quantified as described in the text.
b ABZ1(T) is a transposon-induced TrS derivative of 1003(O), and ABZ1(R)
is a spontaneous TrR derivative of ABZ1(T).
c The induction is relative to the value obtained for 1003(O) (OpS) RNA.

























































TrS derivatives produced R derivatives at readily measurable
frequencies (14). Table 5 shows that TDB3(T) (TrS) produced
only TrS colonies (100% based on a total of 9,698 colonies
counted in three independent switching assays, each conducted
for a total of 15 days) and so produced neither OpS nor TrR
colonies. In contrast, strain RJS2(T), another TrS derivative of
strain 1003(O) (OpS) which was rendered acapsular due to a
transposon insertion in the wcvF gene (45), also produced no
OpS colonies but did produce both TrS colonies (87.3% 
5.9% [mean  standard deviation based on a total of 5,755
colonies counted]) and TrR colonies (5.2%  4.5%) (Table 5).
The switching assay results for strain TDB3(T) (TrS) thus
support the notion that both rEPS and CPS genetic determi-
nants are present in this cluster of genes.
However, it was still possible that although wcrH and wcrI
are clustered with the other wcr genes in sequenced strain
YJ016, these genes may not all be linked in strain 1003(O)
(OpS). To examine wcr gene linkage in strain 1003(O) (OpS),
we used a combination of PCR and Southern hybridization
(see Materials and Methods for details). PCR confirmed the
linkage of four gene pairs; specifically, using primers RUG13
and RUG16, RUG15 and RUG18, RUG19 and RUG34, and
CAP25 and CAP28 (Table 1), linkage was demonstrated be-
tween wcrA and wcrB, wcrB and wcrC, wcrD and wcrF, and
wcrH and wcrI, respectively (data not shown). Radiolabeled
probes specific for wcrC, wcrF, or wcrH all hybridized to the
same 10.5-kb PstI fragment of 1003(O) (OpS) genomic DNA
in Southern blots, as well as to larger individual BamHI and
MluI fragments; these results were anticipated based on the
YJ016 sequence for this genetic region (data not shown).
Based on the w proposed system for nomenclature of bac-
terial genes involved in exopolysaccharide production (36), we
designated this nine-gene locus wcr (capsular and rugose ex-
opolysaccharide). This locus appears to be intact in both YJ016
and strain 1003(O) (OpS); further, a homologous cluster, cor-
responding to ORFs VV21582 to VV21574, was also identified
by BLAST searches of the other sequenced V. vulnificus strain,
CMCP6 (Table 6).
Outside V. vulnificus strains, the products of the wcrABCD
FHIJK cluster showed significant predicted amino acid identity
(range, 49 to 75%) to the products of the cpsABCDFHIJK gene
cluster in Vibrio parahaemolyticus strain BB22 (Table 6), which
are required for CPS expression in this organism (16). Certain
genes in the V. vulnificus cluster also showed identity to genes
in the vps region of the sequenced V. cholerae O1 El Tor
N16961 genome (18). The vps region is involved in rEPS ex-
pression and is divided into two operons (vpsI and vpsII) on a
30.7-kb fragment of the large chromosome of V. cholerae (1,
63). The products of both wcrF and wcrI showed deduced
amino acid identity (31 and 23%, respectively) to products of
genes in the vpsI operon, while the wcrABCD gene products
showed levels of amino acid identity ranging from 28 to 55% to
products of genes in the vpsII operon and the wcrK product
showed 30% amino acid identity to the product of VC0939, a
gene downstream of the vpsII operon. No potential homologs
of either the wcrH or wcrJ gene of V. vulnificus were identified
in the genome of V. cholerae N16961 (18) or any of the other
sequenced V. cholerae strains (Table 6). Finally, homologs of
most of the wcrABCDFHIJK genes of V. vulnificus were also
identified in the genomes of numerous other Vibrio species
(Table 6).
Analysis of the nine-gene wcr locus in V. vulnificus. Using the
web-based FGENESB: Bacterial Operon and Gene Prediction
algorithm (http://www.softberry.com/cgi-bin/programs/gfindb
/fgenesb.pl), two operons were predicted for the nine-gene
locus: wcrABCDF and wcrHIJK (Fig. 5). While no complete
JUMPstart (just upstream of many polysaccharides starts)
sequence (20) was identified 5 to wcrA, an intact 9-bp ops
(operon polarity suppressor) sequence (5-GGGCGGTAG-3)
with a downstream conserved thymine residue (5) was identi-
fied 26 bp upstream of the predicted translational start site of
wcrA and within a putative promoter region, which was pre-
TABLE 6. Identification of the wcr locus in the two sequenced strains of V. vulnificus and distribution of homologs in other Vibrio species
Gene

















wcrA VVA0395 VV21582 cpsA VC0934 VF0352 23265 01001295 05856
wcrB VVA0394 VV21581 cpsB VC0935 VF0351 None 01001294 05851
wcrC VVA0393 VV21580 cpsC VC0936 VF0350 23155 01001293 05846
wcrD VVA0392 VV21579 cpsD VC0937 VF0349 23165 01001292 05841
wcrF VVA0391 VV21578 cpsF VC0925 VFA1035 23230 01001290 05831
wcrH VVA0390 VV21577 cpsH None None None 01001288 05821
wcrI VVA0389 VV21576 cpsI VC0920 VF0344 23230 01001287 05816
wcrJ VVA0388 VV21575 cpsJ None None None 02001743 05811
wcrK VVA0387 VV21574 cpsKg VC0939 None None 02001742 05806
a Genome sequenced by Chen et al. (8).
b Genome sequenced by Kim et al. (25).
c The sequenced strain V. parahaemolyticus 2210633 (29) also has homologs of the wcr genes (VPA1413 to VPA1403), but they are not in the same order as they
are in strain BB22 or in V. vulnificus. The strain BB22 genes were identified by Güvener and McCarter (16).
d Genome sequenced by Heidelberg et al. (18). The gene numbers indicate genes in or near the vpsI and II operons. Homologues for the genes identified in strain
N16961 have also been identified in five other strains of V. cholerae (O395, MO10, V52, V51, and RC385), and genome sequencing is in progress (http://www.ncbi.nlm
.nih.gov/genomes/lproks.cgi). No sequenced strain of V. cholerae possesses homologs of wcrH and wcrJ. Genes required for rEPS expression were first identified in V.
cholerae 1552 by Yildiz and Schoolnik (63); it is not known if strain 1552 possesses homologs of all of the genes in the wcr cluster.
e Genome sequenced by Ruby et al. (38).
f Genome sequencing is in progress (http://www.ncbi.nlm.nih.gov/genomes/lproks.cgi).
g The similarity of wcrK to the putative cpsK gene is based on BLAST comparison of wcrK to the cpsK homolog in V. parahaemolyticus 2210633 (29).

























































dicted (based on a score of 0.97 with a score cutoff of 0.80)
using the web-based Neural Network Promoter Prediction al-
gorithm for prokaryotic sequences (35). A promoter with a
score of 0.97 was also predicted using the same algorithm for
the region between the two putative operons, although no ops
sequence was identified there. Finally, a possible rho-indepen-
dent transcriptional termination site was identified following
the last gene in the cluster, wcrK, by using the database for the
genome of V. vulnificus YJ016 from the web-based trans-
TermHP site (26).
Because recombination between direct repeats and recom-
bination between indirect repeats leading to deletions and
inversions, respectively, are mechanisms of phase variation in
other bacterial species (41, 50), we searched the wcrABCDFHIJK
gene cluster for direct and indirect repeats. Numerous repeats
of both types were identified, and the longest repeat of each
type was 15 bp long. The first 15-bp direct repeat (5-GTCA
CTCGATGAGCT-3) was found in wcrA, and the second was
found in wcrK. The first 15-bp inverted repeat (5-CTTTGTA
TTTCTGAC-3) was identified in the noncoding sequence 5
to wcrA, and the second was identified in wcrF. Both types of
repeats were well represented throughout the cluster, includ-
ing both coding and noncoding regions, and thus recombina-
tion involving either type represents a possible mechanism for
phase variation of CPS and/or rEPS expression.
Many of the genes in the cluster have conserved domains
found in genes encoding proteins known to participate in ex-
pression of lipopolysaccharide (LPS), EPS, and CPS (Table 7).
There are three glycosyltransferases: the product of wcrA,
which has the conserved domain of WcaJ for expression of
colanic acid in Escherichia coli K-12 and other strains with
group 2 capsules (56), and the products of wcrF and wcrI, both
of which have the conserved domain of RfaG (renamed
WaaG), which is involved in synthesis of the LPS core oligo-
saccharide in E. coli and Salmonella enterica (19). The longest
gene in the cluster, wcrD, has two conserved domains. The first
conserved domain encodes GumC, which is involved in group
1 CPS expression in Xanthomonas campestris, and a homolog
of Wzc (PCP-2 [polysaccharide copolymerase]), which func-
tions in O-antigen synthesis as a tyrosine autokinase and con-
tains ATP-binding motifs; the second conserved domain is the
domain encoding Mrp, an ATPase in E. coli (55). The follow-
ing two genes have domains associated with transport: wcrC
(polysaccharide biosynthesis and export) and wcrJ, whose con-
served domain encodes RfbX (renamed Wzx, a flippase). In E.
coli, RfbX is involved in the export of O antigen and teichoic
acid, while Wzx has been reported to be associated with group
1 CPS and colanic acid expression, as well as LPS expression
(32, 55). There are multiple homologs of Wzx, and they have
been grouped recently into PST(1) for CPS expression and
PST(2) for LPS expression (32). It is likely that the wcrJ gene
product is in the latter group based on the conserved domain.
Finally, three genes have either an uncharacterized conserved
domain (wcrB) or no known conserved domain (wcrH and
wcrK).
DISCUSSION
Previously, we demonstrated that OpR and TrR isolates of
V. vulnificus have a number of similarities, including produc-
tion of copious amounts of biofilms and little or no motility
(14). A significant difference between R isolates was also ob-
served, however, upon exposure to NHS; an OpR strain, like
its OpS parent, was relatively resistant to complement-medi-
ated killing, while a TrR strain, like its TrS progenitor, was
sensitive (14). Here, we showed that resistance of OpR strains
to serum killing in vitro correlates with virulence in vivo in the
iron-supplemented mouse model. Given the correlation be-
tween virulence and the presence of capsule, which enables V.
vulnificus to avoid host immune cells and complement (15, 48),
it was not surprising to find that OpR cells retain CPS expres-
sion in addition to producing rEPS, while the avirulent TrR
cells produce only rEPS. These data further illustrate the cen-
tral role in pathogenesis played by CPS in V. vulnificus (15).
Because the TrR strain was avirulent, no direct function in the
pathogenicity of V. vulnificus can be ascertained for rEPS.
Interestingly, studies of the R phenotype in V. cholerae suggest
that the rEPS may promote biofilm formation in vivo and that
during coinfection V. cholerae R cells may assist certain S
strains in pathogenesis (34). It thus remains to be determined
TABLE 7. Genes in the wcr locus of V. vulnificus
Gene Gene no.a Conserved domain(s)b Accession no.a
wcrA VVA0395 WcaJ, sugar transferase involved in LPS (COG2148); polysaccharide
biosynthesis protein (pfam02719)
NP_936451
wcrB VVA0394 Uncharacterized protein conserved in bacteria (COG5338) NP_936450
wcrC VVA0393 Periplasmic polysaccharide biosynthesis/export protein (pfam02563) NP_936449
wcrD VVA0392 GumC (Wzc family), uncharacterized protein involved in exopolysaccharide
biosynthesis (cell envelope biogenesis, outer membrane) (COG3206);
Mrp, ATPase involved in chromosome partitioning (COG0489)
NP_936448
wcrF VVA0391 RfaG (WaaG), glycosyltransferase (cell envelope biogenesis, outer
membrane) (COG0438); glycosyltransferase group 1 (pfam00534)
NP_936447
wcrH VVA0390 No conserved domain NP_936446
wcrI VVA0389 RfaG (WaaG), glycosyltransferase (cell envelope biogenesis, outer
membrane) (COG0438); glycosyltransferase group 1 (pfam00534)
NP_936445
wcrJ VVA0388 RfbX (Wzx), membrane protein involved in the export of O antigen and
teichoic acid (COG2244)
NP_936444
wcrK VVA0387 No conserved domain NP_936443
a Gene numbers and accession numbers for V. vulnificus YJ016 (8).
b Conserved domains were identified by a BLAST search of the NCBI Conserved Domain database.

























































whether rEPS could similarly play a significant, and perhaps
ancillary, role in the pathogenesis of V. vulnificus. It is also
possible that the biofilm-proficient R form of V. vulnificus
instead increases survival of the organism in its normal marine
and estuarine environments (14).
In addition to protection from the bactericidal effects of
NHS, the V. cholerae R phenotype and the V. cholerae rEPS
have been shown to confer protection against low levels of
chlorine disinfectant. V. cholerae R cells survived exposure to
0.5 to 3 g/ml free chlorine, in some instances for at least 30
min, while S cells were killed quickly (2, 31, 37, 63), and
purified rEPS was shown actually to inactivate free chlorine
(63). While R strains have been isolated from numerous V.
cholerae serogroups, including serogroup O1 and the encapsu-
lated serogroup O139, all of the V. cholerae R strains for which
chlorine resistance has been reported were derived from a
nonencapsulated parent strain. In contrast to the findings for
V. cholerae rEPS, the results reported here suggest that V.
vulnificus rEPS does not confer a chlorine survival advantage
to the cells, nor does CPS. While the numbers of TrS strain
ABZ1(T) cells that survived chlorine treatment were signifi-
cantly higher than the numbers of cells of its R derivative
ABZ1(R) that survived, both the OpS strain 1003(O) and its
OpR derivative BG(R) were totally eradicated. These data
strongly suggest that in V. vulnificus it is the absence of CPS
especially, rather than the presence of rEPS, that promotes
survival when cells are exposed to low levels of chlorine disin-
fectant. It has been suggested that bacterial EPS (including
CPS) functions as an ion-exchange substance and also as a
nutrient-trapping substance (9, 49). Perhaps the CPS, which is
covalently bound to the cell, sequesters the OCl ion close to
the cell and allows the chlorine to make contact with the cell
membrane, where it can denature membrane proteins (39),
resulting in membrane disruption and cell death. These results
indicate that while CPS and rEPS may confer adaptive advan-
tages to the bacteria under some conditions, they may also be
a liability under other conditions.
V. cholerae strains are often tested for resistance to chlorine,
but V. vulnificus strains are not. Unlike V. cholerae, V. vulnifi-
cus cannot survive in freshwater and thus is not transmitted
through drinking water, which is often treated with chlorine in
attempts to kill pathogens. It has been reported that a modified
Dakin’s solution (250 g/ml NaOCl) is useful for treatment of
V. vulnificus wound infections in a clinical setting (30, 57). In
another study, in which one V. vulnificus strain was tested for
chlorine resistance, exposure to 500 g/ml NaOCl for 30 min
killed not only V. vulnificus but also V. cholerae and V. para-
haemolyticus (40). All of these studies used a much higher
concentration of NaOCl than the concentration used here, and
no mention was made of colony morphology, but as all V.
vulnificus strains treated were of clinical origin, it is likely that
they were all OpS strains.
A portion of the wcrABCDFHIJK locus was originally iden-
tified as a low-identity (
25% amino acid identity; no DNA
identity) homolog of the V. vulnificus group 1-like CPS operon
containing wza (7, 8). The group 1-like operon is present on
the larger chromosome of V. vulnificus YJ016 and CMCP6 and
of Vibrio species other than V. cholerae, which does not possess
homologs of this operon (7, 8). The wcr gene cluster is present
on the smaller chromosome in both of the sequenced V. vulni-
ficus strains, YJ016 and CMCP6 (8, 25). Smith and Siebeling
(45) reported that wcrHI were on the same approximately
200-kb NotI fragment as the other CPS genes that they iden-
tified. High-identity homologs of only four of the other 12
CPS-related genes are present in the sequenced V. vulnificus
strains, and they are on the large chromosome in both cases (8,
25); thus, the chromosomal location of the wcr genes in strain
1003(O) (OpS) remains undetermined. The wcr cluster ap-
pears to be widespread in numerous Vibrio species and has also
been identified as a CPS operon in V. parahaemolyticus (16).
Curiously, wcrH, wcrJ, and wcrK have no homologs in Vibrio
fischeri or Vibrio splendidus, nor are wcrH and wcrJ present in
any sequenced strain of V. cholerae. Also, the chromosomal
location of this cluster varies in the different species and
strains. The cluster is on the small chromosome of the se-
quenced V. parahaemolyticus (29) and V. splendidus strains,
while its location appears to be mixed in the sequenced V.
fischeri strain (38) and Vibrio sp. strain Ex25 (Table 6). Further,
while the genes in this cluster are linked in the order shown for
V. vulnificus, the gene order does not appear to be conserved
across all the Vibrio species in which they have been identified
(Table 6).
The presence of conserved genes in the wcrABCDFHIJK
locus that may individually or collectively participate in the
synthesis of multiple forms of polysaccharide is consistent with
the results of our phenotypic switching assay for strain
TDB3(T) (TrS), which, because of a transposon insertion in
wcrI, was unable to switch to either the OpS or TrR form; thus,
this mutant is apparently defective for synthesis and/or trans-
port to the cell surface of both CPS and rEPS. The dual
deficiency of both CPS expression and rEPS expression for the
wcrI mutant contrasted with the phenotypic switching assay
results for the wcvF rhamnosyl transferase mutant RJS2(T)
(TrS) presented here, as well as those for the wcvA epimerase
mutant ABZ1(T) (TrS) described previously (14); in both of
the latter cases, only CPS expression was eliminated. It re-
mains to be determined whether the wcrI glycosyltransferase
gene product itself is involved in both CPS and rEPS expres-
sion or whether some of the phenotype of the TDB3(T) (TrS)
mutant can instead be ascribed to a polar effect on downstream
gene expression (i.e., wcrJ and wcrK) by the transposon inser-
tion. In any event, taken together, our results and observations
support the notion that genetic determinants for CPS and
rEPS expression, and possibly LPS expression, are present in
the wcrABCDFHIJK gene cluster.
A group 1-like CPS operon has been described for V. vulni-
ficus (58). It was reported recently that there are at least three
different genotypes that are associated with the spontaneous
appearance of the TrS phenotype and that two of the three
genotypes appear to be the result of accumulated deletions in
the operon, which result in strains that are locked in the TrS
phase (7). Although the genetic basis of the OpS-to-TrS tran-
sition in the spontaneous TrS strain AZ(T) used in our study is
unknown, AZ(T) (TrS) can convert back to the OpS pheno-
type, although it does so infrequently, and it was the only TrS
isolate tested previously that never produced an R derivative
during phenotypic switching assays (14). Thus, it is unlikely
that the TrS phenotype was caused by deletion of genes re-
quired for CPS expression, but it is possible that there may
have been a reversible rearrangement of genes required for

























































both CPS and rEPS in this strain. Whether such a putative
rearrangement actually occurred and, if so, whether the
wcrABCDFHIJK gene cluster identified here was involved
remain to be determined.
Here, we demonstrated further significant differences be-
tween OpR and TrR isolates of V. vulnificus in terms of viru-
lence in vivo, resistance to chlorine, and CPS expression. Ad-
ditionally, we identified a nine-gene cluster that includes both
CPS and rEPS determinants as well as possibly LPS determi-
nants. As expression of these genes appears to be significantly
greater in R variants, the role of each of the genes in biofilm
formation and maintenance remains to be revealed. The exact
contribution of each gene to the different exopolysaccharides,
phase variation, and virulence remains to be determined, but
we are continuing to perform studies to elucidate the function
of each gene, as well as its regulation.
ACKNOWLEDGMENTS
We thank Eric Achberger and Richard Cooper for their support and
guidance. We also express our appreciation for the late V. R. Sriniva-
san and his encouragement and enthusiasm for identification of the
genes involved in bacterial exopolysaccharide production. We thank
Darren Johnson and Jill Jenkins for their assistance with SAS/STAT.
Microscopy was conducted at the Socolofsky Microscopy Center, De-
partment of Biological Sciences, Louisiana State University.
This research was supported by Louisiana Sea Grant College Pro-
gram grant NA16RG2249 to G.S.P. The Louisiana Sea Grant Program
is a part of the National Sea Grant College Program maintained by the
National Oceanic and Atmospheric Administration of the U.S. De-
partment of Commerce.
REFERENCES
1. Ali, A., Z. H. Mahmud, J. G. Morris, Jr., S. Sozhamannan, and J. A.
Johnson. 2000. Sequence analysis of TnphoA insertion sites in Vibrio cholerae
mutants defective in rugose polysaccharide production. Infect. Immun. 68:
6857–6864.
2. Ali, A., M. H. Rashid, and D. K. R. Karaolis. 2002. High-frequency rugose
exopolysaccharide production by Vibrio cholerae. Appl. Environ. Microbiol.
68:5773–5778.
3. Altschul, S. F., T. L. Madden, A. A. Schäffer, J. Zhang, Z. Zhang, W. Miller,
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